Cervical cancer prevention advances with new immunotherapy findings, addressing disparities and improving outcomes for ...

SMARTER SCREENINGS: The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. 'WE WILL FIGHT': OpenAI CEO Sam Altman said ...

Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among never- and under-screened U.S. women, according to a first-of-its-kind ...

Participation in a cervical cancer screening program in a safety-net health system more than doubled when patients received ...

Vepdegestrant showed a benefit for patients with ER-positive, HER2-negative, ESR1-mutated breast cancer who had previously received endocrine-based therapy.

A new study found that women who received mail-in self-collection kits participated in screening at much higher rates than those who just received a telephone reminder.

Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among ...

Arvinas and Pfizer have filed for U.S. Food and Drug Administration approval of their proposed breast-cancer drug vepdegestrant in certain patients with estrogen-receptor mutations.

After becoming popular in the wake of the Me Too movement, at-home sexual assault kits are still facing legal battles. Things ...

The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., ...

Lack of insurance, financial instability and even fear are potential reasons women may forego their cervical cancer screening ...

The researchers found that cervical mucus from Pap smears has a higher cell-free DNA yield than plasma in endometrial cancer cases.